However, the scope of cytoprotection in SCD has not previously been defined, and recent studies in transgenic SCD mice indicate that the level of induction of HO-1 alone is insufficient to neutralize the oxidative burden of the disease [25], [26]. The gene discussed is HMOX1; the disease is Schnyder corneal dystrophy.